Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma

European Journal of Human Genetics

Volumn 15, Issue 10, 2007, Pages 1043-1048

  Majorczyk, Edyta ^a   Jasek, Monika ^a   Płoski, Rafał ^b   Wagner, Marta ^a   Kosior, Anna ^a   Pawlik, Andrzej ^c   Obojski, Andrzej ^d   Łuszczek, Wioleta ^a   Nowak, Izabela ^a   Wiśniewski, Andrzej ^a   Kuśnierczyk, Piotr ^a,e  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

^e JAN DLUGOSZ UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLERGIC ASTHMA; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; POLAND; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARTHRITIS, RHEUMATOID; ASTHMA; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22;

EID: 34848836690     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201879     Document Type: Article

References (25)

1. Bottini N, Vang T, Cucca F, Mustelin T: Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006; 18 207-213.
2. GrSgersen PK, Lee H-S, Batliwalla F, Begovich AB: PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006; 18: 214-223.
3. Bottini N, Musumeci L, Alonso A et al: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337-338.
4. Begovich AB, Carlton VE, Honigberg LA et al: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-337.
5. Dieudé P, Garnier S, Michou L et al: Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele. Arthritis Res Ther 2005; 7: R1200-R1207.
6. Hinks A, Barton A, John S et al: Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population. Further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 2005; 52: 1694-1699.
7. Orozco G, Sanchez E, Gonzalez-Gay MA et al: Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005; 52: 219-224.
8. Michou L, Lasbleiz S, Rat A-C et al: Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci USA 2007; 104: 1649-1654.
9. Rueda B, Núñez C, Orozco G et al: C1858T functional variant of PTPN22 gene is not associated with celiac disease genetic predisposition. Hum Immunol 2005; 66: 848-852.
10. Rottem M, Shoenfeld Y: Asthma as a paradigm for autoimmune disease. Int Arch Allergy Immunol 2003; 132: 210-214.
11. - T cells in patients with rheumatoid arthritis. Arthritis Res Ther 2003; 5: R210-R213.
12. NHLBI/WHO Workshop Report: Global strategy for asthma management and prevention. NIH Publication no. 02-3659, February 2002.
13. Jasek M, Łuszczek W, Obojski A et al: Distribution of CTLA-4 polymorphisms in allergic asthma. Int Arch Allergy Immunol 2006; 141: 223-229.
14. Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Płoski R: Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: Association and gene dose-dependent correlation with age at onset. Clin Endocrinol 2005; 62: 679-682.
15. Pawlik A, Ostanek L, Brzosko I, Gawrońska-Szklarz B, Brzosko M, Dabrowska-Zamojcin E: Increased genotype frequency of N-acetylase 2 slow acetylation in patients with rheumatoid arthritis. Clin Pharmacol Ther 2002; 72: 319-325.
16. Carlton VE, Hu X, Chokkalingam AP et al: PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005; 77: 567-581.
17. Harrison P, Pointon JJ, Farrar C, Brown MA, Wordsworth BP: Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology 2006; 45: 1009-1011.
18. van Oene M, Wintle RF, Liu X et al: Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not with Crohn's disease, in Canadian populations. Arthritis Rheum 2005; 52: 1993-1998.
19. Plenge RM, Padyukov L, Remmers EF et al: Replication of putative candidate-gene associations with rheumatoid arthritis in > 4,000 samples from North America and Sweden: Association of susceptibility with PTPN22, CTLA-4 and PAD14. Am J Hum Genet 2005; 77: 1044-1060.
20. Johansson M, Ärlestig L, Hallmans G, Rantapää-Dahlqvist S: PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res Ther 2006; 8: R19.
21. Vang T, Congia M, Macis MD et al: Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 37: 1317-1319.
22. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 2004; 173: 6418-6426.
23. Falgarone G, Jaen O, Boissier MC: Role for innate immunity in rheumatoid arthritis. Joint Bone Spine 2005; 72: 17-25.
24. Arnett FC: Is scleroderma an autoantibody mediated disease? Curr Opin Rheumatol 2006; 18: 579-581.
25. Wipff J, Allanore Y, Kahan A et al: Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population. Ann Rheum Dis 2006; 65: 1230-1232.